PNC Financial Services Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Buy |
|
|||||
|
2025
Q1 | $1.28M | Buy |
|
|||||
|
2024
Q4 | $1.86M | Sell |
|
|||||
|
2024
Q3 | $1.69M | Sell |
|
|||||
|
2024
Q2 | $2.27M | Buy |
|
|||||
|
2024
Q1 | $3.45M | Sell |
|
|||||
|
2023
Q4 | $7.17M | Buy |
|
|||||
|
2023
Q3 | $4.55M | Sell |
|
|||||
|
2023
Q2 | $11.1M | Buy |
|
|||||
|
2023
Q1 | $4.05M | Buy |
|
|||||
|
2022
Q4 | $3.15M | Buy |
|
|||||
|
2022
Q3 | $3.96M | Buy |
|
|||||
|
2022
Q2 | $2.61M | Buy |
|
|||||
|
2022
Q1 | $2.93M | Buy |
|
|||||
|
2021
Q4 | $612K | Buy |
|
|||||
|
2021
Q3 | $200K | Buy |
|
|||||
|
2021
Q2 | $376K | Hold |
|
|||||
|
2021
Q1 | $255K | Hold |
|
|||||
|
2020
Q4 | $340K | Hold |
|
|||||
|
2020
Q3 | $179K | Buy |
|
|||||
|
2020
Q2 | $164K | Buy |
|
|||||
|
2020
Q1 | $134K | Hold |
|
|||||
|
2019
Q4 | $154K | Sell |
|
|||||
|
2019
Q3 | $210K | Sell |
|
|||||
|
2019
Q2 | $251K | Sell |
|
|||||
|
2019
Q1 | $276K | Buy |
|
|||||
|
2018
Q4 | $124K | Buy |
|
|||||
|
2018
Q3 | $124K | Sell |
|
|||||
|
2018
Q2 | $162K | Buy |
|